Literature DB >> 25914451

Treatment of esophagogastric junction carcinoma: an unsolved debate.

Michele Orditura1, Gennaro Galizia1, Eva Lieto1, Ferdinando De Vita1, Fortunato Ciardiello1.   

Abstract

The incidence of esophagogastric junction adenocarcinoma (AEG) is increasing worldwide. Barrett's esophagus (BE) associated with dysplasia is the main risk factor for the development of cancer. Currently, screening programs to individuate and eradicate BE represent the best way to reduce AEG cancer. Several endoscopic approaches are here discussed. Surgical strategies for different types of AEG cancer are now fairly standardized, and multidisciplinary strategies using chemotherapy or chemoradiotherapy may improve the outcome of these patients. Here we briefly discuss the keypoints, main topics, and critical issues, according to accumulating evidence and taking into account our own experience.

Entities:  

Keywords:  Barrett’s esophagus; Chemoradiotherapy; Chemotherapy; Endoscopic resection; Esophagogastric junction adenocarcinoma; Surgery

Mesh：

Year:  2015        PMID： 25914451      PMCID： PMC4402289          DOI： 10.3748/wjg.v21.i15.4427

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  41 in total

1.  American Gastroenterological Association medical position statement on the management of Barrett's esophagus.

Authors:  Stuart J Spechler; Prateek Sharma; Rhonda F Souza; John M Inadomi; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2011-03       Impact factor: 22.682

2.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

Review 3.  A systematic review of spleen and pancreas preservation in extended lymphadenectomy for gastric cancer.

Authors:  Savtaj S Brar; Rajini Seevaratnam; Roberta Cardoso; Calvin Law; Lucy Helyer; Natalie Coburn
Journal:  Gastric Cancer       Date:  2011-09-14       Impact factor: 7.370

Review 4.  Transthoracic vs transhiatal surgery for cancer of the esophagogastric junction: a meta-analysis.

Authors:  Ming-Tian Wei; Yuan-Chuan Zhang; Xiang-Bing Deng; Ting-Han Yang; Ya-Zhou He; Zi-Qiang Wang
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

6.  Incidence of adenocarcinoma among patients with Barrett's esophagus.

Authors:  Frederik Hvid-Jensen; Lars Pedersen; Asbjørn Mohr Drewes; Henrik Toft Sørensen; Peter Funch-Jensen
Journal:  N Engl J Med       Date:  2011-10-13       Impact factor: 91.245

7.  Totally minimally invasive Ivor-Lewis esophagectomy with single-utility incision video-assisted thoracoscopic surgery for treatment of mid-lower esophageal cancer.

Authors:  W Guo; L Ma; Y Zhang; X Ma; S Yang; X Zhu; J Zhang; Y Zhang; J Xiang; H Li
Journal:  Dis Esophagus       Date:  2014-12-17       Impact factor: 3.429

8.  Proximal gastrectomy with jejunal interposition and TGRY anastomosis for proximal gastric cancer.

Authors:  Ping Zhao; Shuo-Meng Xiao; Ling-Chao Tang; Zhi Ding; Xiang Zhou; Xiao-Dong Chen
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

9.  Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.

Authors:  Andrew R Davies; James A Gossage; Janine Zylstra; Fredrik Mattsson; Jesper Lagergren; Nick Maisey; Elizabeth C Smyth; David Cunningham; William H Allum; Robert C Mason
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

10.  British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus.

Authors:  Rebecca C Fitzgerald; Massimiliano di Pietro; Krish Ragunath; Yeng Ang; Jin-Yong Kang; Peter Watson; Nigel Trudgill; Praful Patel; Philip V Kaye; Scott Sanders; Maria O'Donovan; Elizabeth Bird-Lieberman; Pradeep Bhandari; Janusz A Jankowski; Stephen Attwood; Simon L Parsons; Duncan Loft; Jesper Lagergren; Paul Moayyedi; Georgios Lyratzopoulos; John de Caestecker
Journal:  Gut       Date:  2013-10-28       Impact factor: 23.059
View more
  1 in total

1.  Dorsal Track Control (DTC): A Modified Surgical Technique for Atraumatic Handling of the Distal Esophagus in Esophagojejunostomy.

Authors:  Nadja Lehwald-Tywuschik; Fabian Steinfurth; Feride Kröpil; Andreas Krieg; Hülya Sarikaya; Wolfram Trudo Knoefel; Martin Krüger; Tahar Benhidjeb; Morris Beshay; Jan Schulte Am Esch
Journal:  J Gastric Cancer       Date:  2019-10-23       Impact factor: 3.720
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.